-Dow Jones
Oppenheimer Initiates Coverage On Icosavax with Outperform Rating, Announces Price Target of $27
Oppenheimer analyst Hartaj Singh initiates coverage on Icosavax (NASDAQ:ICVX) with a Outperform rating and announces Price Target of $27.